AngioInsight has announced the enrolment of the first patient in the SMARTFLOW clinical study, assessing AngioAI+, the company’s investigational software platform designed to assess coronary physiology from routine coronary angiographic images. The prospective, multicentre SMARTFLOW study is co-led by Carlos Collet, director of cardiovascular imaging, physiology and translation therapeutics at the Cardiovascular Research Foundation (CRF, […] The post SMARTFLOW trial of AI-powered coronary physiology assessment tool gets underway appeared first on Cardiovascular News .